1.
Gastrointestinal tolerability and quality of life in antiretroviral-naïve HIV-1-infected patients: data from the CASTLE study
by Malan, Niel
AIDS care, 2010-06-01, Vol.22 (6), p.677-686

2.
96-Week Efficacy and Safety of Atazanavir, With and Without Ritonavir, in a HAART Regimen in Treatment-Naive Patients
by Malan, D.R.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002), 2010-01, Vol.9 (1), p.34-42
